These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Prevention of community-acquired pneumonia in adults]. Barros M M; Cartagena S C; Bavestrello F L Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421 [TBL] [Abstract][Full Text] [Related]
27. Fulminant septicaemia. Mazdai G; Burke GJ Ir Med J; 1996; 89(6):228. PubMed ID: 8996956 [No Abstract] [Full Text] [Related]
28. [Pneumococcal vaccination]. Léophonte P Rev Mal Respir; 1999 Nov; 16(5):763-6. PubMed ID: 10612144 [No Abstract] [Full Text] [Related]
29. [Pneumococcal vaccination--why so rare?]. Persili SA; Kuhn M; Wieland T Praxis (Bern 1994); 1997 Jul; 86(27-28):1097-100. PubMed ID: 9324717 [TBL] [Abstract][Full Text] [Related]
30. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991 [TBL] [Abstract][Full Text] [Related]
31. [Polyvalent pneumococcal vaccine]. Ferrari M; Micozzi A Recenti Prog Med; 1983 Feb; 74(2):249-52. PubMed ID: 6867455 [No Abstract] [Full Text] [Related]
32. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Hedlund JU; Kalin ME; Ortqvist AB; Henrichsen J Arch Intern Med; 1994 Sep; 154(17):1961-5. PubMed ID: 8074600 [TBL] [Abstract][Full Text] [Related]
34. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study. Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174 [TBL] [Abstract][Full Text] [Related]
35. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Hak E; Grobbee DE; Sanders EA; Verheij TJ; Bolkenbaas M; Huijts SM; Gruber WC; Tansey S; McDonough A; Thoma B; Patterson S; van Alphen AJ; Bonten MJ Neth J Med; 2008 Oct; 66(9):378-83. PubMed ID: 18990781 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744 [TBL] [Abstract][Full Text] [Related]
37. [Pneumococcal vaccination in obstructive lung diseases -- what can we expect?]. Rose M; Lode H; de Roux A; Zielen S Dtsch Med Wochenschr; 2005 Mar; 130(9):461-5. PubMed ID: 15731959 [TBL] [Abstract][Full Text] [Related]
39. Drug-resistant pneumonia on the increase but vaccine now available. J Okla State Med Assoc; 1995 Jul; 88(7):315. PubMed ID: 7650568 [No Abstract] [Full Text] [Related]